PEPG pepgen.com Earnings per share growth this year
PepGen Inc. maintains a minimal environmental footprint due to a lack of manufacturing plants, which is explained by the specific nature of the biotech sector. The annual EPS growth rate visualizes the financial dynamics, where 49.30 shows the value of this parameter. The EDO patent platform for muscle-targeted drug delivery alleviates concerns. This unique therapy method for rare pathologies paves the way for monopoly pricing power in the future.
Financial and market metric breakdowns for pepgen.com (PEPG)
- stock value and consensus price forecast:
- market capitalization data:
- book capitalization information:
- debt and solvency information:
- net income and valuation multiples indicators:
PEPG - Company Net Income|Forward Earnings PepGen Inc.|PEPG - P/E Multiple|Forward Price to Earnings Multiple PepGen|PEPG - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation PepGen Inc.|PEPG - Operating profit EBITDA|Net earnings per one share for the last twelve months PepGen|PEPG - Net earnings per share for the last 12 months|Quarterly EPS earnings growth pepgen.com|PEPG - Earnings per share growth in current year|Expected earnings per share trend next year PepGen Inc.
- sales volume and revenue information:
Summary company analysis:PEPG - PepGen Corp
This indicator reflects the year-over-year growth rate of net earnings per share. By analyzing the history of annual EPS changes, an investor tracks the dynamics of real income relative to the previous period. The metric is calculated as the percentage deviation of the current EPS from the value at the same point last year. For PepGen Inc. (PEPG), this metric is critical during the transition from R&D to drug commercialization. Earnings growth would confirm the successful scalability of the company's intellectual property in the global market.
Main competitors
Earnings per share growth rate in current year Biogen Inc (BIIB)|Earnings per share growth in current year Neurocrine Biosciences Inc|Earnings per share growth this year RGC (Regencell Corp)|Net earnings per share growth this year AXSM (Axsome Therapeutics)|ACAD (acadia-pharm.com) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon)|Expected net earnings per share growth this year Viking Therapeutics Inc (VKTX)|SUPN - Earnings per share growth in current year|CPRX (Catalyst Corp) - Earnings per share growth this year|DNLI: Earnings growth in current year|Net earnings per share growth this year harmonybiosciences.com|Net earnings per share growth this year BHVN|Amylyx Pharmaceuticals Inc (AMLX) - Expected net earnings per share growth this year|Earnings per share growth in current year Trevi Pharma (TRVI)|PRAX: Earnings per share trend in current year|Earnings growth in current year AVXL (Anavex Life Sciences)|ceribell.com (CBLL) - Earnings per share growth rate in current year|PRTA - Earnings per share growth in current year|Earnings per share trend in current year ALEC|ANNX: Earnings growth in current year|Net earnings per share change in current year Omeros OMER|Earnings per share growth in current year Neurogene Inc.|Earnings per share growth this year ACIU (acimmune.com)|Earnings growth in current year VYGR|NMRA - Earnings per share growth rate in current year|Scilex Holding Co. - Net earnings per share growth this year|Earnings growth in current year Tevogen Bio Inc. TVGN|ACOG - Earnings per share growth in current year|Earnings per share increase in current year CGTX (Cognition Therapeutics Inc.)|Inhibikase Therapeutics, Inc. (IKT) - Earnings per share growth in current year|Earnings per share growth rate in current year Cassava Sciences Inc (SAVA)|Earnings per share growth in current year Assertio Holdings|Coya - Earnings per share trend in current year|Earnings growth in current year VTGN|OVID - Earnings per share growth rate in current year|Earnings per share growth in current year Acumen Pharmaceuticals, Inc. ABOS|CRVO (CervoMed, Inc.) - Earnings per share trend in current year|Alterity Therapeutics Ltd - Earnings growth in current year|Net earnings per share change in current year Clene Inc. (CLNN)|JUNS: Earnings growth in current year|Earnings per share growth rate in current year relmada.com (RLMD)|Earnings per share growth in current year Annovis Bio|Earnings per share growth this year GRCE (Grace Tx)|Net earnings per share growth this year AIFF (Firefly Neuroscience Inc)|KLTO (anewmeds.com) - Earnings per share increase in current year|Earnings growth in current year NRSN (NeuroSense Therapeutics Ltd.)|Expected net earnings per share growth this year revivapharma.com (RVPH)|MTVA - Earnings per share growth in current year|NRXS (NeurAxis Inc.) - Earnings per share growth this year|HSDT: Earnings growth in current year|Net earnings per share growth this year Passage Bio|Net earnings per share growth this year NEUP|minervaneurosciences.com (NERV) - Expected net earnings per share growth this year|Earnings per share growth in current year Athira Pharma (ATHA)|ADXN: Earnings per share trend in current year|Earnings growth in current year ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Earnings per share trend in current year KTTA|CRGT: Earnings growth in current year|Net earnings per share change in current year Avenue Therapeutics Inc. ATXI|Earnings per share growth in current year Brainstorm Cell Therapeutics, Inc.|Earnings per share growth this year CARA (Cara Therapeutics Inc)|Earnings growth in current year CHRO|ELYM - Earnings per share growth rate in current year|Intra-Cellular Therapies, Inc. - Net earnings per share growth this year|Earnings growth in current year Longboard Pharmaceuticals Inc LBPH|MRNS - Earnings per share growth in current year|Earnings per share increase in current year NKGN (NKGen Biotech Corp)|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|Earnings per share growth rate in current year sagerx.com (SAGE)|Earnings per share growth in current year Synaptogenix|Trevena Inc. - Earnings per share trend in current year|Earnings growth in current year VIGL|WENA - Earnings per share growth rate in current year|Earnings per share growth in current year Cerevel Therapeutics CERE
